IAS2017 – Community Paris Declaration published

24/07

At the IAS2017 Conference, Paris, 24/07/2017 It is international AIDS conferences that ignite minds and mark turning points in the…

Lay Summaries workshop: Report now out!

23/07

Today the results from clinical trials are usually discussed within the scientific community only and are seldom spread to the…

1st Interim Meeting for ESTICOM

20/07

EATG participated in the 1st Interim Meeting of the ESTICOM project (http://www.esticom.eu) in Brussels on 17-18/7. ESTICOM is, to some extent,…

IAS2017 – Community Paris Declaration published

24/07

At the IAS2017 Conference, Paris, 24/07/2017 It is international AIDS conferences that ignite minds and mark turning points in the…

HIV i-Base: Fit for purpose 2017

24/07

Fit for purpose 2017 is a publication of HIV i-Base summarising key developments in antiretroviral treatment optimisation for adults and…

Experimental HIV vaccine regimen is well-tolerated, elicits immune responses

24/07

Results from early-stage NIH-funded trial support further development of candidate vaccines. Results from an early-stage clinical trial called APPROACH show…

IAS2017 – Community Paris Declaration published

24/07

At the IAS2017 Conference, Paris, 24/07/2017 It is international AIDS conferences that ignite minds and mark turning points in the…

Lay Summaries workshop: Report now out!

23/07

Today the results from clinical trials are usually discussed within the scientific community only and are seldom spread to the…

1st Interim Meeting for ESTICOM

20/07

EATG participated in the 1st Interim Meeting of the ESTICOM project (http://www.esticom.eu) in Brussels on 17-18/7. ESTICOM is, to some extent,…

IAS2017 – Community Paris Declaration published

24/07

At the IAS2017 Conference, Paris, 24/07/2017 It is international AIDS conferences that ignite minds and mark turning points in the…

HIV i-Base: Fit for purpose 2017

24/07

Fit for purpose 2017 is a publication of HIV i-Base summarising key developments in antiretroviral treatment optimisation for adults and…

Experimental HIV vaccine regimen is well-tolerated, elicits immune responses

24/07

Results from early-stage NIH-funded trial support further development of candidate vaccines. Results from an early-stage clinical trial called APPROACH show…